ENTACOVER 0.5: Comprehensive Guide on Entecavir IP (0.5mg) Treatment.

ENTACOVER 0.5

Entecavir IP (0.5mg)

ENTACOVER 0.5 offers a targeted approach in the management of hepatitis B infection. Containing 0.5 mg of Entecavir IP, a potent nucleoside analog antiviral drug, it effectively inhibits the replication of the hepatitis B virus (HBV), helping to reduce the viral load and prevent the progression of the disease to more serious conditions such as cirrhosis and liver cancer.

Composition

The main ingredient in ENTACOVER 0.5 is:

• Entecavir IP (0.5mg): Known for its high potency and efficacy in the inhibition of viral DNA synthesis, which is critical in the lifecycle of the hepatitis B virus.

Uses

ENTACOVER 0.5 is used for:

• Treatment of chronic hepatitis B virus infection in adults and adolescents who show evidence of active viral replication and elevated liver enzymes or histologically active disease.
• Long-term suppression of HBV replication.

Dosage and Administration

ENTACOVER 0.5 is typically administered once daily on an empty stomach, at least 2 hours before or after meals. The duration of treatment may be indefinite, depending on the clinical response and doctor’s recommendations. Patients are advised to follow their doctor's instructions carefully to ensure optimal results.

Side Effects

While taking ENTACOVER 0.5, some patients may experience side effects, including:

• Headache
• Fatigue
• Dizziness
• Nausea
• Elevated liver enzymes

Rare but more severe side effects could include lactic acidosis and liver complications, which necessitate immediate medical attention.

Price

The price of ENTACOVER 0.5 can vary significantly depending on geographical location, insurance coverage, and pharmacy pricing policies. Patients should check with their local pharmacies or healthcare providers for specific pricing information.

Precautions

Patients with pre-existing liver disease, kidney disease, or those on other antiviral medications should use ENTACOVER 0.5 with caution. Regular monitoring by a healthcare provider, including liver function tests and viral load assessments, is crucial to safely manage treatment.

Conclusion

ENTACOVER 0.5 is a critical component in the treatment strategy for chronic hepatitis B, offering patients an effective means to manage their infection and improve liver health. Its precise dosing of Entecavir IP ensures that it can be effectively integrated into various treatment regimes, tailored to individual patient needs. As with any antiviral treatment, adherence to prescribed regimens and regular medical supervision are key to achieving the best outcomes and minimizing potential risks. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. gynecology, Pediatrics, Dental care, and Dermatology.The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW